BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16937735)

  • 21. Cancer risk in HIV-infected persons: influence of CD4(+) count.
    Clifford GM; Franceschi S
    Future Oncol; 2009 Jun; 5(5):669-78. PubMed ID: 19519206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human papillomavirus vaccine: the beginning of the end for cervical cancer.
    Bornstein J
    Isr Med Assoc J; 2007 Mar; 9(3):156-8. PubMed ID: 17402325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple infections and cancer: implications in epidemiology.
    Vedham V; Divi RL; Starks VL; Verma M
    Technol Cancer Res Treat; 2014 Apr; 13(2):177-94. PubMed ID: 23919392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The epidemiology of anal human papillomavirus and related neoplasia.
    Palefsky JM; Rubin M
    Obstet Gynecol Clin North Am; 2009 Mar; 36(1):187-200. PubMed ID: 19344856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of cancer through immunization: Prospects and challenges for the 21st century.
    Frazer IH; Lowy DR; Schiller JT
    Eur J Immunol; 2007 Nov; 37 Suppl 1():S148-55. PubMed ID: 17972339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Can we prevent or cure infection-related cancers?].
    Gisserot O; Romeo E; Boudin L; Tsitsi Nding Tsogou P; Abed S; Bladé JS; de Jauréguiberry JP
    Rev Med Interne; 2014 Apr; 35(4):259-63. PubMed ID: 24359725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Close relationships between microorganisms and cancer].
    Luján Cuestas M
    Rev Argent Microbiol; 2014; 46(3):173-4. PubMed ID: 25444123
    [No Abstract]   [Full Text] [Related]  

  • 28. Will vaccination against human papillomavirus prevent eye disease? A review of the evidence.
    Hughes DS; Powell N; Fiander AN
    Br J Ophthalmol; 2008 Apr; 92(4):460-5. PubMed ID: 18369059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant vaccines for the prevention of human papillomavirus infection and cervical cancer.
    Palmer KE; Jenson AB; Kouokam JC; Lasnik AB; Ghim SJ
    Exp Mol Pathol; 2009 Jun; 86(3):224-33. PubMed ID: 19454268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Human papillomavirus and carcinoma of the cervix vaccines against the human papillomavirus-promise of an efficacious prevention].
    Kohl I
    Klin Mikrobiol Infekc Lek; 2006 Jun; 12(3):91-7. PubMed ID: 17051469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases.
    Clifford G; Franceschi S; Diaz M; Muñoz N; Villa LL
    Vaccine; 2006 Aug; 24 Suppl 3():S3/26-34. PubMed ID: 16950015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors.
    Balamurugan A; Ahmed F; Saraiya M; Kosary C; Schwenn M; Cokkinides V; Flowers L; Pollack LA
    Cancer; 2008 Nov; 113(10 Suppl):2919-25. PubMed ID: 18980275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimates of Cancer Mortality Attributable to Carcinogenic Infections in Italy.
    Ferrara P; Conti S; Agüero F; Albano L; Masuet-Aumatell C; Ramon-Torrell JM; Mantovani LG
    Int J Environ Res Public Health; 2020 Nov; 17(23):. PubMed ID: 33255366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The macroecology of cancer incidences in humans is associated with large-scale assemblages of endemic infections.
    Jacqueline C; Abbate JL; Sorci G; Guégan JF; Thomas F; Roche B
    Infect Genet Evol; 2018 Jul; 61():189-196. PubMed ID: 29578085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chapter 15: HPV vaccine use in the developing world.
    Kane MA; Sherris J; Coursaget P; Aguado T; Cutts F
    Vaccine; 2006 Aug; 24 Suppl 3():S3/132-9. PubMed ID: 16950000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology of cancer: Indian scenario.
    Prasad RR; Yadava DK
    J Indian Med Assoc; 2005 Sep; 103(9):483-5. PubMed ID: 16493869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural history and epidemiology of HPV infection and cervical cancer.
    Castellsagué X
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S4-7. PubMed ID: 18760711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV infection and cancer in the era of highly active antiretroviral therapy (Review).
    Barbaro G; Barbarini G
    Oncol Rep; 2007 May; 17(5):1121-6. PubMed ID: 17390054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial and fungal meningitis in patients with cancer.
    Safdieh JE; Mead PA; Sepkowitz KA; Kiehn TE; Abrey LE
    Neurology; 2008 Mar; 70(12):943-7. PubMed ID: 18347316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.
    Goldie SJ; O'Shea M; Diaz M; Kim SY
    Reprod Health Matters; 2008 Nov; 16(32):86-96. PubMed ID: 19027626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.